Expert Insights for Health Science Companies

As a global leader in health science M&A, recapitalization, and growth financing strategies, Crosstree has led 100+ transactions for companies at the center of this fast-moving industry.

Resource

Innovations in Pharmaceutical Development™
Crosstree’s in-depth guide to the most innovative people, companies, and solutions in pharma services.

February 8, 2021

Introducing Innovations in Pharmaceutical Development™ In this first-of-its-kind book, Crosstree profiles over 50 of the most innovative companies and thought…

Read Resource
BlueBook

Pharma Services March 2021

Standigm has closed a $44.5mm round of funding BrightInsight closed a $101mm round of funding, led by General Catalyst Evidation...

BlueBook

Diagnostics & Tools March 2021

Roche has agreed to acquire GenMark Diagnostics for $1.9bb Agilent Technologies has agreed to acquire Resolution Bioscience for approximately $700mm...

BlueBook

Diagnostics & Tools February 2021

Veracyte has agreed to acquire Decipher Biosciences for $670mm Exact Sciences Corporation has agreed to acquire Ashion Analytics for $140mm...

BlueBook

Pharma Services February 2021

ICON has agreed to acquire PRA Health Sciences for approximately  $12bb Veristat has acquired SQN Clinical Altasciences has acquired WCCT...

View All

We were impressed with the intensity and thoroughness of Crosstree’s preparation. Their team worked tirelessly on analytics and positioning, ultimately giving us the flexibility to efficiently navigate various strategic options involving our business and each of its two divisions. I wouldn’t think twice about using Crosstree again.

Crosstree did an exceptional job with our process. We benefited greatly from their industry knowledge, expansive network, deal expertise and just plain hard work. Most importantly, their bankers demonstrated sterling integrity and always gave us sound advice that resulted in an excellent outcome, despite numerous twists and turns along the way.

Crosstree’s specific knowledge of our market segment allowed them to precisely target potential buyers. Further, Crosstree guided management to the right “value drivers” for each potential buyer, optimally tuning our various presentations, and ultimately driving enhanced valuations during the auction process.

Explore greater market insights and financial possibilities with the leading experts in health science.

Jeff Ellis

Jeff Ellis

Co-Founder & Managing Director
Shane Senior, CFA

Shane Senior, CFA

Co-Founder & Managing Director
Frederic Laurier

Frederic Laurier

Managing Director
Zeke Navar

Zeke Navar

Managing Director
Rusty Ray

Rusty Ray

Managing Director
Gordon Ryerson

Gordon Ryerson

Managing Director
Lance Converse

Lance Converse

Managing Partner - Crosstree Equity Fund
Roman Margolin

Roman Margolin

Managing Partner - Crosstree Equity Fund
Christian Carlson, PhD

Christian Carlson, PhD

Director
Jason Layton

Jason Layton

Director
Patti-Ann Dresback

Patti-Ann Dresback

Director of Operations
Zach Hungate

Zach Hungate

Vice President
Reid Petersen

Reid Petersen

Vice President
Andrew Barry

Andrew Barry

Associate
Stefanie Hilton

Stefanie Hilton

Associate
Jay Sojdehei

Jay Sojdehei

Associate
Camden Anderson

Camden Anderson

Analyst
Jake Curtis

Jake Curtis

Analyst
Nic Gianelli

Nic Gianelli

Analyst
Frank Harris

Frank Harris

Analyst
Ryan Silvester

Ryan Silvester

Analyst
Dominic Stockey

Dominic Stockey

Analyst
Jamie Keithahn, CFA

Jamie Keithahn, CFA

Associate
Michael Levin

Michael Levin

Associate
Anne Juarez

Anne Juarez

Analyst
Zach Zientarski

Zach Zientarski

Analyst
Ray Lens

Ray Lens

Research Analyst
Daria Puttick

Daria Puttick

Operations Manager
Meet Our Experts